Dry Eye Disease

LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Yolande Barnard, vice president and general manager, U.S. Pharmaceuticals, Bausch + Lomb, offers updates on the company’s pipeline.

Results from a retrospective chart review on dry eye disease and low vision showed low vision patients are at risk for dry eye disease, but low numbers of dry eye disease tests are performed in low vision eye exams.

LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Eric D. Donnenfeld, MD, discusses the FDA phase 2 trial of risuteganib in patients with dry eye disease.

LAS VEGAS — In this Healio Video Perspective from Eyecelerator@ASCRS, Edward J. Holland, MD, discusses Eysuvis (loteprednol etabonate ophthalmic suspension 0.25%, Kala Pharmaceuticals) and its utility for patients with dry eye disease.

LAS VEGAS — At the Eyecelerator@ASCRS meeting, Jeffrey Nau, PhD, MMS, president and CEO of Oyster Point Pharma, discusses OC-01 nasal spray for dry eye disease and two additional pipeline programs.

LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Mitchell A. Jackson, MD, discusses his practice’s experience participating in a real-world study investigating Dexycu (dexamethasone intraocular suspension 9%, EyePoint).

LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Marguerite B. McDonald, MD, FACS, offers thoughts on using steroids to treat dry eye disease.

LAS VEGAS — When evaluating a patient for dry eye before refractive surgery, older techniques can be important tools along with newer tests, according to a presentation at the American Society of Cataract and Refractive Surgery meeting.

Everything about dry eye disease is hard.

Lower Schirmer’s test score correlated with increased corneal staining and more severe disease burden among patients with dry eye disease, according to research presented at the Association for Research in Vision and Ophthalmology meeting.